INSIGHTS ON CLINICAL TRIAL DESIGN
-
ICH E6(R3) Annex 2: Navigating GCP Requirements For Decentralized Trials
Implementing decentralized components or real-world data requires proactive alignment with updated GCP standards for data access, remote consent, and multi-stream investigator oversight.
-
At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights
Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.
-
How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch
Embedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Automation Testing In RTSM Software: What Is It And What's The Impact2/25/2026
Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study4/17/2025
This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.
-
Bridging The Gap Between Protocol And Execution In Clinical Trials7/20/2026
Transform passive trial operations into active infrastructure. Learn how a digitized execution layer builds in compliance, enables effective AI, and frees teams for critical decision-making.
-
Innovative Approaches In Oncology Clinical Trials2/6/2025
By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.
-
De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital9/3/2025
For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.
CLINICAL TRIAL DESIGN SOLUTIONS
-
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
CSS offers customized patient recruitment and retention solutions across the globe, ensuring successful enrollment for clinical trials across various therapeutic areas.
-
Help your study team curb trial costs and delays by monitoring adherence in near real time. These tools automate reporting and issue alerts to maximize data capture and regulatory readiness.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
Discover Scout's strategies for elevated, eco-friendly face-to-face and hybrid events. ecoScout for Meetings takes a comprehensive approach to minimizing carbon emissions and maintaining the highest standards of quality and service.